A/S Novo Insider Trading $ANAB ANAPTYSBIO, INC
Get free email notifications about insider trading for A/S Novo.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of A/S Novo. A/S Novo is 10% Owner in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM) and 10% Owner in BIOMIMETIC THERAPEUTICS, INC. ($BMTI) and 10% Owner in Apollo Endosurgery, Inc. ($LPTN) and 10% Owner in Inogen Inc ($INGN) and 10% Owner in Tobira Therapeutics, Inc. ($TBRA) and 10% Owner in KalVista Pharmaceuticals, Inc. ($KALV) and 10% Owner in CoLucid Pharmaceuticals, Inc. ($CLCD) and 10% Owner in REATA PHARMACEUTICALS INC ($RETA) and 10% Owner in ANAPTYSBIO INC ($ANAB) and 10% Owner in iRhythm Technologies, Inc. ($IRTC) and 10% Owner in Milestone Pharmaceuticals Inc. ($MIST) and 10% Owner in Ophthotech Corp. ($OPHT) and 10% Owner in Flexion Therapeutics Inc ($FLXN) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Bolt Biotherapeutics, Inc. ($BOLT) and 10% Owner in Checkmate Pharmaceuticals, Inc. ($CMPI) and 10% Owner in Morphic Holding, Inc. ($MORF) and 10% Owner in Praxis Precision Medicines, Inc. ($PRAX) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in Eargo, Inc. ($EAR) and 10% Owner in Reneo Pharmaceuticals, Inc. ($RPHM) and 10% Owner in Entasis Therapeutics Holdings Inc. ($ETTX) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and 10% Owner in Aligos Therapeutics, Inc. ($ALGS) and 10% Owner in SPRUCE BIOSCIENCES, INC. ($SPRB) and 10% Owner in Harmony Biosciences Holdings, Inc. ($HRMY).
A/S Novo in ANAPTYSBIO, INC
Trading Symbol: ANABIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of A/S Novo: 10% Owner
Holdings: 1,936,604 shares
Current Value: $35,904,638
Latest Transaction: Aug 21 2017
$ANAB Market Capitalization: $365.89M
$ANAB Previous Close: $18.54
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of A/S Novo in ANAPTYSBIO, INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALGS, ANAB, LPTN, BMTI, BOLT, CMPI, CLCD, CRVS, EAR, EWTX, ETTX, FLXN, GRTX, HRMY, HTGM, INGN, INZY, IRTC, OPHT, KALV, MIST, MIRM, MORF, NKTX, PRAX, RARX, RETA, RPHM, SPRB, TBRA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 21 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | S | 21.10 | 356,300 | 7,518,251 | 1,936,604 | 2.3 M to 1.9 M (-15.54 %) |
Aug 16 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | S | 21.00 | 143,428 | 3,011,988 | 2,292,904 | 2.4 M to 2.3 M (-5.89 %) |
Aug 16 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | S | 21.79 | 35,172 | 766,493 | 2,436,332 | 2.5 M to 2.4 M (-1.42 %) |
Aug 08 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | S | 22.92 | 1,023 | 23,443 | 2,471,504 | 2.5 M to 2.5 M (-0.04 %) |
Aug 08 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | S | 21.10 | 480,000 | 10,128,000 | 2,472,527 | 3 M to 2.5 M (-16.26 %) |
Aug 08 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | S | 22.00 | 10,271 | 225,963 | 2,952,527 | 3 M to 3 M (-0.35 %) |
Aug 03 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | S | 22.01 | 21,451 | 472,192 | 2,962,798 | 3 M to 3 M (-0.72 %) |
Aug 03 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | S | 23.87 | 25,700 | 613,485 | 2,984,249 | 3 M to 3 M (-0.85 %) |
Aug 03 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | S | 23.87 | 23,555 | 562,270 | 3,009,949 | 3 M to 3 M (-0.78 %) |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Option Exercise | X | 4.55 | 117,235 | 533,419 | 0 | |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 673,454 | 0 | 0 | |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 312,986 | 0 | 0 | |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 486,820 | 0 | 0 | |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 1,428,571 | 0 | 0 | |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | P | 15.00 | 50,000 | 750,000 | 3,033,504 | 3 M to 3 M (+1.68 %) |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | X | 0.00 | 81,673 | 0 | 2,983,504 | 2.9 M to 3 M (+2.81 %) |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | C | 0.00 | 673,454 | 0 | 2,901,831 | 2.2 M to 2.9 M (+30.22 %) |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | C | 0.00 | 312,986 | 0 | 2,228,377 | 1.9 M to 2.2 M (+16.34 %) |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | C | 0.00 | 486,820 | 0 | 1,915,391 | 1.4 M to 1.9 M (+34.08 %) |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | C | 0.00 | 1,428,571 | 0 | 1,428,571 | 0 to 1.4 M |
Page: 1